analysis of thyroid cancer treatment（分析甲状腺癌的治疗）.docVIP

Analysis of thyroid cancer treatment [Keywords] 131I; thyroid cancer; papillary carcinoma; follicular thyroid carcinoma The present study in patients with thyroid cancer have been treated as a standard implementation of 131I [1] .131 I treatment, including ‘A clear’ and ‘treatment’, ‘A clear’ means the use of 131I to destroy residual normal thyroid tissue after surgery, because Thyroid cancer is multiple, postoperative residual thyroid cancer cells may be the remnants of the thyroid. ‘therapy’ refers to the residual 131I treatment of thyroid cancer thyroid bed, thyroid bed tumor lesions and metastases, we used 131I treatment of thyroid cancer patients After 85 patients, efficacy significantly. 1 Materials and methods 1.1 General Information The pathological diagnosis of papillary carcinoma or follicular thyroid cancer, 85 cases, including 34 males, female 51 cases; aged 18 to 82 years old, 31 to 60 years old accounted for 69.4% of all patients underwent subtotal resection of the thyroid or full resection, subtotal resection of which 7 cases, 45 cases of Hysterectomy, Hysterectomy + unilateral cervical lymph node dissection in 19 cases, all resection + bilateral cervical lymph node dissection in 14 cases. line first surgery, 62 cases of reoperation in 18 cases, three operations in 5 patients there were 72 cases of cervical lymph node metastasis, no lymph node metastasis were 13 cases of thyroid nodules in an 23 cases, a leaves with 2 nodules in 12 cases, so the leaves have a more nodules and 50 cases. violation of thyroid nodules capsule, muscle, trachea, cricoid cartilage in 25 cases, no local invasion in 60 cases. Pathological type of papillary carcinoma in 75 cases, 88.2%, follicular carcinoma in 5 cases, accounting for 5.9%, nipple + follicular carcinoma in 5 cases, accounting for 5.9%. Ⅰ period 10 patients, Ⅱ period in 32 patients, accounting for 37.6%, Ⅲ period in 31 patients, accounting for 36.5%, Ⅳ period of 12 patients, accounting for